AEON – aeon biopharma, inc. class a (US:NASDAQ)
Stock Stats
News
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
AEON Biopharma (NASDAQ:AEON) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth
AEON Biopharma (NASDAQ:AEON) had its "buy" rating reaffirmed by analysts at Aegis. They now have a $7.20 price target on the stock.
Form 8-K AEON Biopharma, Inc. For: Dec 04
Form DEFA14A AEON Biopharma, Inc.
Form 10-Q AEON Biopharma, Inc. For: Sep 30
Form 8-K AEON Biopharma, Inc. For: Nov 14
Form 8-K AEON Biopharma, Inc. For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.